SODIUM PHENYLACETATE AND SODIUM BENZOATE
Details
- Status
- Prescription
- First Approved
- 2016-02-24
- Routes
- INTRAVENOUS
- Dosage Forms
- SOLUTION
Companies
SODIUM PHENYLACETATE AND SODIUM BENZOATE Approval History
What SODIUM PHENYLACETATE AND SODIUM BENZOATE Treats
3 indicationsSODIUM PHENYLACETATE AND SODIUM BENZOATE is approved for 3 conditions since its original approval in 2016. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Hyperammonemia
- Encephalopathy
- Urea Cycle Disorder
Drugs Similar to SODIUM PHENYLACETATE AND SODIUM BENZOATE
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
SODIUM PHENYLACETATE AND SODIUM BENZOATE FDA Label Details
ProIndications & Usage
FDA Label (PDF)Sodium Phenylacetate and Sodium Benzoate Injection is a nitrogen binding agent indicated as adjunctive therapy for the treatment of acute hyperammonemia and associated encephalopathy in paediatric and adult patients with deficiencies in enzymes of the urea cycle. Sodium Phenylacetate and Sodium Benzoate Injection is indicated as adjunctive therapy in pediatric and adult patients for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle. During acute hyperammonemic episodes, arginine supplementation, caloric supplementatio...
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.